TranS1 Inc. Announces CE Mark for VEO(TM) Minimally Invasive Lateral Access Fusion System
July 03, 2012 07:30 ET
|
Baxano Surgical, Inc.
WILMINGTON, N.C., July 3, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a pioneer in minimally invasive approaches to lumbar spine surgery, today announced it has received CE (Conformité...
TranS1 Inc. Announces Participation in Two Investor Conferences in June 2012
May 30, 2012 16:30 ET
|
Baxano Surgical, Inc.
WILMINGTON, N.C., May 30, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today it will participate in two investor conferences in June.
Ken Reali, President and Chief Executive...
TranS1 Inc. Reports Operating Results for the First Quarter of 2012, Issues Second Quarter 2012 Guidance
May 08, 2012 16:01 ET
|
Baxano Surgical, Inc.
First quarter revenues were $3.8 million
Net loss per share was $0.21 for the quarter
WILMINGTON, N.C., May 8, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company...
TranS1 Inc. to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
May 02, 2012 07:30 ET
|
Baxano Surgical, Inc.
WILMINGTON, N.C., May 2, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that Ken Reali, President and Chief Executive Officer, and Joe Slattery, Executive Vice President and Chief...
TranS1 Inc. Schedules First Quarter 2012 Results Conference Call for Tuesday, May 8, 2012
April 25, 2012 16:01 ET
|
Baxano Surgical, Inc.
WILMINGTON, N.C., April 25, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that it plans to release first quarter 2012 financial and operating results after market close on...
TranS1 Appoints Jeffrey Fischgrund, M.D. to Board of Directors
April 05, 2012 07:30 ET
|
Baxano Surgical, Inc.
WILMINGTON, N.C., April 5, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing spine products to treat degenerative conditions...
TranS1 Inc. Reports Operating Results for the Fourth Quarter of 2011, Issues First Quarter 2012 Guidance
March 08, 2012 16:01 ET
|
Baxano Surgical, Inc.
- Fourth quarter revenues were $4.0 million -
- 310 TranS1 procedures performed globally in the quarter -
- Launch of VEOTM Lateral Access and Interbody Fusion System -
- Net loss per share...
Category I Code Approved for TranS1's AxiaLIF Pre-Sacral Interbody Fusion
March 05, 2012 07:00 ET
|
Baxano Surgical, Inc.
WILMINGTON, N.C., March 5, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing minimally invasive spine products to treat...
TranS1 Inc. Opens New Training Facility in Raleigh, NC
February 24, 2012 07:30 ET
|
Baxano Surgical, Inc.
WILMINGTON, N.C., Feb. 24, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing minimally invasive spine products to treat...
TranS1 Inc. Schedules Fourth Quarter 2011 Results Conference Call for Thursday, March 8, 2012
February 23, 2012 09:00 ET
|
Baxano Surgical, Inc.
WILMINGTON, N.C., Feb. 23, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that it plans to release fourth quarter 2011 financial and operating results after market close on...